International Aids Vaccine Initiative

This early-stage study tests a new vaccine designed to prevent Sudan virus disease, a severe and often deadly illness. About 112 healthy adults aged 18 to 50 will receive either the vaccine or a placebo to check for side effects and measure immune responses. The goal is to see if…